Přehled o publikaci
2022
Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers
MATEJOVÁ, Gabriela, Martin RADVAN, Eliška BARTEČKOVÁ, Martin KAMENÍK, Lumír KOC et. al.Basic information
Original name
Cardiac sequelae after COVID-19: Results of a 1-year follow-up study with echocardiography and biomarkers
Authors
MATEJOVÁ, Gabriela, Martin RADVAN, Eliška BARTEČKOVÁ, Martin KAMENÍK, Lumír KOC, Jana HOŘÍNKOVÁ, Ľubica SÝKOROVÁ, Radka ŠTĚPÁNOVÁ and Petr KALA
Edition
Frontiers in Cardiovascular Medicine, Lausanne, Frontiers, 2022, 2297-055X
Other information
Language
English
Type of outcome
Article in a journal
Country of publisher
Switzerland
Confidentiality degree
is not subject to a state or trade secret
References:
Organization
Lékařská fakulta – Repository – Repository
UT WoS
000906974000001
EID Scopus
2-s2.0-85145507190
Keywords in English
COVID-19; SARS-CoV-2; echocardiography; troponin; NT-proBNP; survilence
Links
LX22NPO5107, research and development project.
Changed: 6/4/2023 04:59, RNDr. Daniel Jakubík
Abstract
V originále
lt; 0.001), while no right ventricle dysfunction was detected. There was very mild progress in left ventricle diastolic diameter [median (IQR) change 1.0 (−1.0; 4.0) mm; p = 0.001] between V1 and V3, mild enlargement of the left atrium (mean change 1.2 ± 4.17 mm; p = 0.021) and a non-significant trend to impairment of left ventricle diastolic dysfunction. There was a mild change in pulmonary artery systolic pressure [median (IQR) change 3.0 (−2.0; 8.0) mmHg; p = 0.038]. Conclusion: Despite a lot of information regarding cardiac impairment due to SARS-CoV2, our study does not suggest an increased risk for developing clinically significant heart changes during the 1-year follow-up. Based on our results, routine echocardiography and biomarkers collection is currently not recommended after COVID-19 recovery.
